Adagio Medical Holdings Inc
Research Adagio Medical Holdings Inc (ADGM) on Bullrun: market cap USD 2.89M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerADGM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 2.89M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 6.72M
- Free cash flow-USD 5.27M
Valuation Snapshot
latest market cap is USD 2.89M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 25.08M | -USD 19.39M | n/a | -1.51 | USD 17.11M | USD 21.04M | USD 12.40M |
| FY2024 | USD 602.00K | -USD 75.79M | -USD 31.11M | -451.2% | -14.09 | USD 20.59M | USD 17.18M | USD 19.91M |
| FY2023 | USD 300.00K | -USD 36.59M | -USD 25.99M | -335.3% | -48.16 | USD 1.38M | USD 38.27M | -USD 132.02M |
| FY2022 | USD 189.00K | -USD 23.67M | -USD 22.91M | -363.0% | -1.77 | USD 5.55M | USD 9.80M | -USD 95.88M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 2.89M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 23.10M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 15.96M | n/a | n/a | n/a |
About Adagio Medical Holdings Inc
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Adagio Medical Holdings Inc's market cap?
Adagio Medical Holdings Inc's market capitalization is USD 2.89M.
What does Adagio Medical Holdings Inc do?
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.